Furthermore, current studies regarding the predictive performance of CRP and PCT were focused on short-term prognosis of COVID-19 infection (27), whereas the association between inflammatory biomarkers with long-term prognosis in diabetic patients with COVID-19, especially with ADC remains uncertain. This evidence concerns the gene CRP and COVID-19.